Machleidt, A., Buchholz, S., Diermeier-Daucher, S., Zeman, F., Ortmann, O., & Brockhoff, G. (2013). The prognostic value of Her4 receptor isoform expression in triple-negative and Her2 positive breast cancer patients. BioMed Central.
Stile di citazione ChicagoMachleidt, Anna, Stefan Buchholz, Simone Diermeier-Daucher, Florian Zeman, Olaf Ortmann, e Gero Brockhoff. The Prognostic Value of Her4 Receptor Isoform Expression in Triple-negative and Her2 Positive Breast Cancer Patients. BioMed Central, 2013.
Citazione MLAMachleidt, Anna, et al. The Prognostic Value of Her4 Receptor Isoform Expression in Triple-negative and Her2 Positive Breast Cancer Patients. BioMed Central, 2013.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.